As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

其中，Recursion Pharmaceuticals这颗星辰耀眼，股价一举上涨超过7%，引领了这一板块的强势反弹。作为一家专注于利用AI技术加速药物发现的生物制药公司，Recursion凭借其独特的技术平台和丰富的研发管线，备受资本市场青睐。公司致力于通过深度学习和生物数据分析来识别和开发潜在的治疗方案，近期关于其药物研发的积极进展无疑为投资者注入了信心。

There’s plenty of empty lab space around Greater Boston these days, and a lot of competition for life-science tenants. Now ...

每经AI快讯，2月24日，美股AI医疗概念股盘前强势上行，Recursion Pharmaceuticals涨超7%，Tempus AI、Ginkgo Bioworks涨超5%，10x Genomics涨超2%。

波士顿 - 基因组学应用公司Volta Labs已将其Callisto™样品制备系统整合到Ginkgo Bioworks的Illumina测序工作流程中，旨在简化和自动化基因组学研究中的复杂流程。在纽约证券交易所上市（股票代码：DNA）的Ginkgo Bioworks以其细胞编程和生物安全平台而闻名。根据 InvestingPro ...

Ginkgo Bioworks' restructuring has resulted in a dramatic reduction in cash burn in recent quarters. Read why I think DNA ...

Ginkgo Bioworks falls short on Q4 revenue and projects weak 2025 guidance. Learn about DNA stock's valuation risks, cash ...

Ginkgo’s headquarters at 27 Drydock Ave. spans some 320,000 square feet, with leases that run from 2030 through 2036. The ...

2月24日，美股AI医疗概念股盘前强势上行，Recursion Pharmaceuticals涨超7%，Tempus AI、Ginkgo Bioworks涨超5%，10x Genomics涨超2%。

Ginkgo already canceled its plans to move into Biofab1, a new 260,000-square-foot lab data center it's been building near its ...

Cell Engineering revenue $110M-$130M with potential upside from the recent launch of Tools offerings Ginkgo expects Biosecurity ...

Ginkgo Bioworks (DNA) is down -12.5%, or -$1.29 to $9.00.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...